We extend the c4c Feasibility System to include site evaluations that capture expertise not typically found in routine databases.
We identify significant patient groups and provide a comprehensive quality control and summary of available sites.
We optimize your clinical trials by minimizing the number of sites, selecting top-tier sites based on specific trial requirements.
Types of Outreach:
Small: Early interest in a study and determine the available population (Y/N).
Medium: Engage potential sites early on with a survey of up to 10 questions, which we facilitate, prefill, and perform a quality check upon completion.
• Site Facilitation & Engagement:
We bridge communication gaps by offering facilitation in local languages, ensuring clarity between sponsors and sites.
If you encounter any challenges, from lack of communication to quality concerns, we're here to troubleshoot.
We also offer support in facilitating the contracting and budgeting processes, although we don't negotiate specific costs.
Additional Services
• CDA Completion
For c4c studies we follow a cascading CDA model; for others we have a CDA-tailered approach according to the sponsors needs.
• Feasibility
We assist in completion, quality control, and provide comprehensive summaries.
• Consultancy on National Procedures
We offer insights into anticipated timelines, both national and local.
Benefit from our protocol review methodology (WP4 ##tabblad)) and support in addressing feedback or comments from local and national regulatory bodies.
• Post-SIV Support
If you face recruitment delays or challenges with adverse event reporting, we're here to assist.
We also help with communication facilitation, especially if you encounter challenges with site team responsiveness.